Level Four Advisory Services’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,011
| Closed | -$761K | – | 843 |
|
|
2023
Q1 | $761K | Buy |
21,011
+887
| +4% | +$32.1K | 0.05% | 338 |
|
|
2022
Q4 | $718K | Sell |
20,124
-7,423
| -27% | -$265K | 0.05% | 318 |
|
|
2022
Q3 | $932K | Buy |
27,547
+2,369
| +9% | +$80.2K | 0.09% | 217 |
|
|
2022
Q2 | $728K | Buy |
25,178
+9,959
| +65% | +$288K | 0.07% | 273 |
|
|
2022
Q1 | $492K | Buy |
15,219
+1,138
| +8% | +$36.8K | 0.04% | 397 |
|
|
2021
Q4 | $411K | Buy |
+14,081
| New | +$411K | 0.03% | 450 |
|